Document Detail

Effects of signal regulatory proteinalpha1 on proliferation of hepatocellular carcinoma: a preliminary study.
MedLine Citation:
PMID:  15908323     Owner:  NLM     Status:  MEDLINE    
BACKGROUND: Signal regulatory protein alpha1 (Sirpalpha1) is a negative regulatory factor, and inhibits receptor tyrosine kinase-dependent cell proliferating signal. This study was undertaken to observe the effect of signal regulatory proteinalpha1 (Sirpalpha1)on gankyrin,cyclin D1,CDK4 and Fas expression in Sk-hep1 mouse hepatoma carcinoma cell line. METHODS: BOSC 23 packed cells were respectively transfected by means of recombinated retrovirus including pLXSN, pLXSN- Sirpalpha1 and pLXSN- Sirpalpha1P4Y2 with lipofectin, and various plasmid virus media(viral titer 2.1X10(6) CFU/ml) were collected and infected respectively in 80% confluent Sk-hep1 cells. Transfected Sk-hep1 cells were selectively screened with G418 (1200 mug/ml), and Sk-hep1 cell lines transfected with various plasmids were obtained. The protein expressions of gankyrin, cyclin D1, CDK4 and Fas in various Sk-hep1 lines were determined by Western blotting. Various Sk-hep1 lines were recovered to culture with 10% fetal bovine serum at 12 hours and 24 hours after starving culture with free serum for 72 hours, and cells were collected to determine the percentage of S phase cells of proliferating cycle by flow cytometry. RESULTS: Sirpalpha1 transfection remarkably downregulated gankyrin and cyclin D1 expression. Sirpalpha1P4Y2 downregulation of gankyrin expression was greater than that of Sirpalpha1 (P<0.05), but no significant effect of Sirpalpha1 and Sirpalpha1P4Y2 on CDK4 and Fas protein expression was observed in transfected Sk-hep1 lines (P>0.05). The percentage of S phase cells significantly decreased in Sk-hep1 cells transfected with Sirpalpha1 and Sirpalpha1P4Y2 plasmids (vs pLXSN Sk-hep1, P<0.05). The percentage of S phase cells in various Sk-hep1 cells increased when recovering to culture with 10% fetal bovine serum at 12 hours, but the percentage of S phase cells in Sk-hep1 cells transfected with Sirpalpha1 was the lowest (vs pLXSN and Sirpalpha1P4Y2 Sk-hep1, P<0.05). The percentage of S phase cells in transfected pLSXN Sk-hep1 cells was the largest (vs Sirpalpha1 and Sirpalpha1P4Y2 Sk-hep1, P<0.05). There was no significant difference between the transfected Sirpalpha1 Sk-hep1 cells and Sirpalpha1P4Y2 Sk-hep1 cells (P>0.05). CONCLUSIONS: Sirpalpha1 decreases gankyrin and cyclin D1 expression, and inhibits proliferation of liver carcinoma cells. It may be one of the forms for an Sirpalpha1 negative regulation of carcinogenesis and development of hepatocellular carcinoma.
Jian-Min Qin; He-Xin Yan; Xing-Wang Wan; Shu-Qin Liu; Jin-Zhang Zeng; Hui-Fang Cao; Meng-Chao Wu; Hong-Yang Wang
Related Documents :
9665653 - Over-expression of acetylcholinesterase stimulates the expression of agrin in ng108-15 ...
11285203 - Repair of sulfur mustard-induced dna damage in mammalian cells measured by a host cell ...
63243 - Identification of cells in culture.
Publication Detail:
Type:  Comparative Study; Journal Article; Research Support, Non-U.S. Gov't    
Journal Detail:
Title:  Hepatobiliary & pancreatic diseases international : HBPD INT     Volume:  4     ISSN:  1499-3872     ISO Abbreviation:  HBPD INT     Publication Date:  2005 May 
Date Detail:
Created Date:  2005-05-23     Completed Date:  2005-07-05     Revised Date:  2009-11-19    
Medline Journal Info:
Nlm Unique ID:  101151457     Medline TA:  Hepatobiliary Pancreat Dis Int     Country:  China    
Other Details:
Languages:  eng     Pagination:  244-8     Citation Subset:  IM    
International Cooperative Laboratory on Signal Transduction, Eastern Hepatobiliary Surgery Institute, Second Military Medical University, Shanghai 200438, China.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Analysis of Variance
Blotting, Western
Cell Line, Tumor
Cell Proliferation / drug effects*
Cyclin D1 / metabolism*
Hepatocytes / physiology*
Mitogen-Activated Protein Kinase 3 / pharmacology*
Oncogene Proteins / analysis,  metabolism
Proteasome Endopeptidase Complex
Proto-Oncogene Proteins
Reg. No./Substance:
0/Oncogene Proteins; 0/PSMD10 protein, human; 0/Proto-Oncogene Proteins; 136601-57-5/Cyclin D1; EC Protein Kinase 3; EC Endopeptidase Complex

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Magnetic resonance angiography in the management of patients with portal hypertension.
Next Document:  Isolation and short term cultivation of swine hepatocytes for bioartificial liver support system.